Streetbeat News

Products Services

SLB

TTE

SLB has been awarded a contract by TotalEnergies for a 13-well subsea production system in the Kaminho Project offshore Angola. The project will be developed in two phases for the Cameia and Golfinho discoveries.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:01 pm

AMIX

Autonomix Medical's Chief Medical Officer, Dr. Robert Schwartz, discussed preliminary positive results from the first five 'lead-in' patients in the company's ongoing human clinical trial for pancreatic cancer pain. The results were reviewed in a virtual investor segment titled 'What This Means.'

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:00 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) shares are experiencing volatility following reports that the company has no plans to produce vehicles with Volkswagen under their recently announced joint venture. The joint venture will focus on creating next-generation software-defined vehicle platforms, with Volkswagen investing $1 billion initially and an additional $4 billion over time.

Portfolio Pulse from Adam Eckert

July 03, 2024 | 1:00 pm

MAXN

Maxeon Solar Technologies (NASDAQ:MAXN) shares surged by 11% after the company was granted a U.S. patent for a protection coating for solar cell wafers. This innovation could enhance the efficiency, durability, or cost-effectiveness of their solar cells, providing a competitive edge and potential revenue boosts through licensing or partnerships.

Portfolio Pulse from Henry Khederian

July 03, 2024 | 12:57 pm

TSLA

Ben Smith, co-founder and editor-in-chief of Semafor, commented on CNBC's 'Last Call' that Tesla's sales are declining, potentially due to CEO Elon Musk's political stance. Despite being an amazing company, Tesla is not selling as many cars as it used to, and competitors are faring better in the EV industry. Musk's controversial social media posts and political leanings may be driving some buyers away.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 12:57 pm

REGN

SNY

The European Medicines Agency (EMA) has approved Sanofi and Regeneron's Dupixent for use in treating chronic obstructive pulmonary disease (COPD) in adults, marking the first approval of its kind globally. This approval is based on positive results from the phase 3 BOREAS and NOTUS studies. The FDA has requested additional data before making a decision on Dupixent's approval for COPD in the US.

Portfolio Pulse from Vandana Singh

July 03, 2024 | 12:55 pm

ICU

SeaStar Medical shares are trading higher after the company finalized FDA labeling requirements for QUELIMMUNE.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 12:49 pm

LAES

SEALSQ Corp (NASDAQ: LAES) reports a new business pipeline of $71M and a cash position of $19M as of June 30, 2024. Preliminary unaudited revenue for H1 2024 is $5M, reflecting a slowdown in traditional semiconductor demand. The company anticipates a stronger H2 2024 and a return to growth in 2025.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 12:49 pm

TSLA

Tesla Inc (NASDAQ:TSLA) has extended its offer to transfer Full Self-Driving (FSD) capability from older vehicles to new ones until the end of September. This extension allows customers to make new purchases until after the robotaxi unveiling event on August 8, which is expected to highlight Tesla's advancements in autonomous driving.

Portfolio Pulse from Anan Ashraf

July 03, 2024 | 12:43 pm

VTRS

Viatris Inc. (NASDAQ: VTRS) has completed the divestiture of its Over-the-Counter (OTC) business to Cooper Consumer Health, finalizing all previously announced divestitures. This move aims to simplify and strengthen the company, positioning it for future growth.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 12:33 pm